Incidence and survival impact of pulmonary arterial hypertension among patients with systemic lupus erythematosus: a nationwide cohort study.
Hung-An ChenTsai-Ching HsuSu-Ching YangChia-Tse WengChun-Hsin WuChien-Yao SunChun-Yu LinPublished in: Arthritis research & therapy (2019)
PAH is a rare complication of SLE and the majority of PAH cases occur within the first 5 years following SLE diagnosis. Systemic hypertension may be a risk factor for PAH development in the SLE population. The overall 5-year survival rate after PAH diagnosis was 70.1%.